Oncomark

Delphi Diagnostics

This company develops genomic tests for breast cancer to assist clinicians and patients in personalising treatment decisions and predicting long-term survival outcomes.

Oxford Cancer Biomarkers

This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.

Oxford Biomarkers

This company develops AI-driven precision diagnostic tests and biomarkers to help clinicians personalise cancer treatments and identify chemotherapy toxicity risks for patients.

Spotlight Medical

This company develops AI-driven prognosis tests to help oncologists select the most effective treatments for cancer patients.

Digistain

This company develops a diagnostic test using infrared spectroscopy to provide breast cancer recurrence-risk stratification for oncologists and multidisciplinary clinical teams.

Inbiomotion

This company develops a gene expression biomarker test to help oncologists select early breast cancer patients for adjuvant treatment with bisphosphonates.

Luminate Medical

This company develops wearable medical devices to prevent chemotherapy side effects and facilitate at-home cancer treatment for oncology patients and healthcare providers.

Oncobit

This company develops precision diagnostic assays and cloud-based monitoring software for clinicians to track cancer markers and therapy response in oncology patients.